Researchers from Boston University School of Medicine (BUSM) have estimated that one in six women are at risk for developing Alzheimer’s disease (AD) in their lifetime, while the risk for men is one in ten. These findings were released today by the Alzheimer’s Association in their publication 2008 Alzheimer’s Disease: Facts and Figures.
Stroke and dementia are the most widely feared age-related neurological diseases, and are also the only neurological disorders listed in the ten leading causes of disease burden.
The researchers followed 2,794 participants of the Framingham Heart Study for 29 years who were without dementia. They found 400 cases of dementia of all types and 292 cases of AD. They estimated the lifetime risk of any dementia at more than one in five for women, and one in seven for men.
“The realization that the lifetime risk of stroke or dementia was more than one in three in both sexes, which is higher than the lifetime risk of coronary heart disease in women, is sobering,” said lead author Sudha Seshadri, MD, an associate professor of neurology at BUSM and an investigator of the Framingham Heart Study.
According to the researchers, the greater lifetime expectancy for women translates into a greater lifetime risk of several diseases.
“People should be aware of the risk of a disease at some point in their life. Similarly, such statistics are essential for public health planners to estimate the projected disease burden in a population during its expected lifespan,” adds Seshadri.
Source: Boston University
Related stories:
Researchers find gene linked to severe diabetic eye and kidney diseases
Researchers at the John A. Moran Eye Center at the University of Utah and collaborative institutions have identified a gene called erythropoietin (EPO) that contributes to increased risk of severe diabetic eye and kidney diseases, called retinopathy and nephropathy.
Discovery of a novel mechanism for the development of colon cancer
Recent work from the Finnish Academy Center of Excellence on Cancer Biology at the University of Helsinki, Finland, has shed light on the mechanisms of colon tumor development and may help to design better treatment for this disease.
Alcoholism is not just a 'man's disease' anymore
Cross-sectional studies, which collect information at a single point in time, generally find that young Americans report having more lifetime alcohol problems than older Americans, despite having had less time to develop these problems. But these studies are hampered by the fact that people of different ages may remember or report problems to different degrees.
MRI's high false positive rate has little impact on women's choice of preventive mastectomy
Magnetic resonance imaging (MRI) falsely detects breast cancer in five out of every six positive scans according to new research into the use of MRI for women with a high, inherited risk of developing the disease. However, this high rate of false positives does not have a major impact on a woman’s decision whether or not to have a prophylactic mastectomy.
Low exposure to asbestos-like mineral from Montana vermiculite may up lung disease risk
Workers exposed to low levels of an asbestos-like mineral from Montana more than two decades ago are at an increased risk for lung disease today, according to research from the University of Cincinnati (UC).
Poor sleep more dangerous for women
Researchers at Duke University Medical Center say they may have figured out why poor sleep does more harm to cardiovascular health in women than in men.
Smokers might benefit from earlier colon cancer screening
New evidence suggests screening for colorectal cancer, which is now recommended to begin at age 50 for most people, should start five to 10 years earlier for individuals with a significant lifetime exposure to tobacco smoke, a University of Rochester Medical Center study said.
Anxiety linked to newly diagnosed DCIS patients' overestimation of breast cancer risks
Elevated levels of anxiety may cause women with ductal carcinoma in situ (DCIS), the most common form of non-invasive breast cancer, to overestimate their risk of recurrence or dying from breast cancer, suggests a study led by researchers at Dana-Farber Cancer Institute in Boston.